BambamPoop

CytRx Announces First of Two Positive Developments Ahead

YOur record is on the wall for ALL to see., Merry F Christmas you Jerk. The next time you try another MCLN Pump and Dump I hope NO ONE buys IT And you get burned!

CytRx Announces First of Two Positive Developments Ahead

all the BIOMEDREPORTS subscribers are now BAGHOLDERS!!! The cronies got special advance word last week....and the subscribers got the word on Sunday. The Cronies all bought between 1 and 4 cents and the open on Monday was 5 cents!!!! all the BMR scrubscribers got HOSED. Let that be a lesson to you all

CytRx Announces First of Two Positive Developments Ahead

What bothers me is the spike just before a Garza report on just bout any pump. It's not illegal, but an ethical breach to be sure. You gotta wonder about Sundays stock pick. How long can he milk the bagholders until we become them.

BioMed News: Antigenics, Shire, King Pharma, Delcath Systems

Mike,

What happened to your site? mikehavrx.com ? discontinued? or just temporarily down?

bambampoop

Celldex Therapeutics: Plenty of Cash, Pending Clinical Catalysts

MSBT is just Joe Krueger's pumpababy.....I don't know if the science is sound or not,,..... but Kruger knows how to make money REGARDLESS of the science...


On Oct 20 10:17 AM User 468004 wrote:

> Mike:
> I'm a follower of yours and receive email updates when you write
> an article. I've made about $30,000 this year (from an initial investment
> of $5000 in March) by buying NEPH, CTIC and HEB near their lows.
> (I was up about 1100% but gave some back.:) The question I have for
> you regards MSBT and their blood purification systems. I own it at
> present, roughly 30K shares, but I don't have the same feeling of
> "look what I've found" as I did with others, including IMGG. Any
> thoughts on the stock, one way or the other?

FDA Calendar Extreme Trades: 85 Single Digit Stocks

85? ...well at least the odds are greatly reduced that someone is going to whine about being left out. LOL

Access Pharma: ProLindac, MuGard Updates

That works for me, Good luck. and we will see you at MikeHavRX.com

Access Pharma: ProLindac, MuGard Updates

I can appreciate that. I have been to mikehavrx.com and checked it out. I already knew you had no position in IMGG from your disclosure at the end of the article. Still, you have to admit that on the face of it, it appears that someone planned to benefit from the IMGG article's publication. I advise my friends to be very wary of the articles at BMR, and only trust the FDA Calendar for investing purposes. The rest of it seems like simple pumping. I hope that the Calendar will be kept up-to-date by someone else if you depart.

Bam

Access Pharma: ProLindac, MuGard Updates

Mike,

I can see how hoopdreamer feels this way.
You have to admit that it looks fishy when a stock rises 54% on no news immediately before you publish an article. Look at IMGG on Friday Sept. 11. Your article for subscribers, and the other one for the general public hit the Biomedreports today, just before the next trading day. While I appreciate your services, especially the calendar, and I am a subscriber, Sometimes I have to do a doubletake at the "coincidence" of events.

Bam

Steer Clear of Sears - Barron's

Sears Holdings is on about the same ethical level as AIG, Cerebus, or Bernie Madoff. The leadership are a bunch of scammers and con-men just like Conway was. They lie and cheat and don't pay their bills. I hope they go totally under

Nuvo Research Worth Buying

Nuvo couldn't get above 40 cents last time, and that was Before they sold the bulk of the future profits away for a one time payment. I don't think you will see much more than 40 cents again this time.

Oculus's New Product Can Tap into Several Billion Dollar Markets

I actually have a subscription, and I can tell you that the information for subscribers is different and better than what non- subscribers see. The real value though, is not the articles, but the calendar that Havrilla provides. It paid for itself many times over and I have only had the subscription for about 6 months


On Aug 22 02:36 PM dreamdivers wrote:

> Yes, I agree. I don't consider biomedreports a reliable source of
> information, and would never pay a dime for a subscription. Too many
> of the articles are written by people who don't seem to have any
> scientific or medical training. And even worse, the due diligence
> often seems limited to "the CEO said", etc.

Oculus's New Product Can Tap into Several Billion Dollar Markets

What bothers me is the affiliation with Biomedreports. I have always considered them to be a reliable source of information. Articles like this make me scrutinize all Biomedreports articles a little closer

Tracking Healthcare Trends and More

Mike, this is NOT a user-friendly site. I couldn't find costs either, and half the links I clicked on didn't work. I wasted at least 30 minutes on this site and this is the second time I followed you there to take a look. It says "Beta" at the top....and I can understand why.

15 Overvalued Small Caps from Russell 2000

I agree with sevepc..... JAV should not be on this list. I suppose after the PDUFA you could re-evaluate, but until then how can you put any value on this?


On Jul 08 06:00 PM SevePC wrote:

> How you can include drug/diagnostic development stage companies in
> this list is beyond comprehension.